Trial intelligence / Profile preview

Xuefu Zhuyu capsule (new process) for post-traumatic headache

CTR20140357Phase 2Completed

Sponsor
Tianjin Hongrentang Pharmaceutical
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Xuefu Zhuyu Jiaonang in post-traumatic headache (PTH), sponsored by Tianjin Hongrentang Pharmaceutical. Started Aug 2014; status: completed.

02

Drugs

Xuefu Zhuyu Jiaonang
03

Conditions

post-traumatic headache (PTH)

Beyond the preview

Go deeper on CTR20140357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call